Biomagnetics Diagnos (BMGP) 0.0007 $BMGP Delving into

New Post Public Reply Private Reply Replies (0) Message Board
Stock_Tracker
Biomagnetics Diagnos (BMGP) 0.0007 $BMGP

Delving into Stem Cell Research and its Potential: 2015 Study
M2 - Mon Jun 29, 10:11AM CDT
Research and Markets (http://www.researchandmarkets.com/research/f9rhn9/delving_into_stem) has announced the addition of the "Delving into Stem Cell Research and its Potential" report to their offering. Stem cells are primal cells found in all multi-cellular organisms that retain the ability to renew themselves through mitotic cell division and can differentiate into a wide range of specialized cell types. As stem cells can be readily grown and transformed into specialized cells with characteristics consistent with cells of various tissues such as muscles or nerves through cell culture, their use in medical therapies has been proposed. In particular, embryonic cell lines, autologous embryonic stem cells generated through therapeutic cloning, and highly plastic adult stem cells from the umbilical cord blood or bone marrow are touted as promising candidates. There exists a widespread controversy over stem cell research that emanates from the techniques used in the creation and usage of stem cells. Human embryonic stem cell research is particularly controversial because, with the present state of technology, starting a stem cell line requires the destruction of a human embryo and/or therapeutic cloning. This research brings you an entire in-depth study of a very niche subject in the wide field of stem cells - Stem Cell Research and its Potential. The report looks at the various types of stem cells which exist and the different benefits each of them offer. The much-talked about embryonic stem cell research and adult stem cell research is discussed in-depth in the report. A separate section covers all the medical uses of stem cell research as well as exploring the potential of stem cell research and therapies. Challenges, barriers, benefits of stem cells, a look at the global approach to stem cell research, and an analysis of the leading players in this industry are what make this report a must-have! Key Topics Covered: A. Executive Summary B. Introduction to Stem Cells C. Looking into Stem Cell Research D. Potential of Stem Cell Research & Therapies E. Benefits of Stem Cell Therapies F. Barriers & Challenges in Stem Cell Research G. Stem Cell in Medical Use H. Trends in the Industry I. Funding for Stem Cell Research J. Global Approach to Human Stem Cell Research K. Industry Outlook L. Leading Players in Stem Cell Research M. Appendix N. Glossary of Terms Companies Mentioned - Amgen - Apceth Gmbh & Co. Kg - Athersys - Bioheart, Inc. - Biomagnetics Diagnostics Corporation - BioTime, Inc. - Brainstorm Cell Therapeutics Inc - Caladrius Biosciences Inc - Celera Corporation (Quest Diagnostics) - Cesca Therapeutics - Cryo-Cell International - CytoGenix, Inc. - Cytori Therapeutics Inc - Gamida Cell Ltd. - Geron Corporation - International Stem Cell Corporation (ISCO) - Microchip Technology Inc. - Neuralstem, Inc. - Ocata Therapeutics - Osiris Therapeutics, Inc. - StemCells Inc - Tigenix NV - Transition Therapeutics Inc. - Vericel Corporation For more information visit http://www.researchandmarkets.com/research/f9..._into_stem
KOOL: 3.70 (+0.66), OCAT: 8.47 (+0.01), VCEL: 2.51 (-0.17), MCHP: 52.66 (-0.33), TTHI: 0.83 (+0.05), OSIR: 5.00 (-0.05), AMGN: 156.94 (-1.06), CLBS: 0.55 (unch), BCLI: 2.49 (-0.05), CYTX: 2.26 (-0.12), GERN: 2.85 (-0.10), DGX: 78.72 (-0.14), CUR: 0.32 (-0.03)

Scroll down for more posts ▼

Top 10 Most Recent News Articles

Webull Faces Class Action Suit: Key Deadlines Loom

Updated Category News Views 302

The Clock is Ticking for Webull Investors If anyone's got a Webull stake, listen up! You’ve got a deadline that's staring you in the face: December 7, 2026. This is when you need to throw your hat in the ring to be a lead plaintiff in the Webull Corporation class action. We're talking securities fraud, folks, with allegations flying that would make your head spin....

Continue Reading
Cleaner Air in Bedroom May Stabilize Blood Sugar Levels

Updated Category News Views 377

Imagine a world where simply sleeping in cleaner air could affect your blood sugar. Seems far-fetched, I know. But that's where we're at with this new study out of NYU Langone Health. They're talking about using plain ol' portable air filters to help steady blood sugar levels for folks dealing with prediabetes. Turns out a cleaner bedroom might just hold the key to taming...

Continue Reading
Fibocom LTE Modules Test Drive Satellite Connectivity

Updated Category News Views 180

Boosting IoT with Satellite Connectivity Here's a good one for folks watching the edge of wireless innovation. Fibocom's LTE Cat.1 bis modules, the LE270-EU and LE271-GL, just stretched their legs in New Zealand, connecting seamlessly with SpaceX's Direct to Cell (DTC) satellite system. No fancy hardware swaps, just standard firmware strutting its stuff across satellite...

Continue Reading
Amplifon Data Breach Spurs Legal Scrutiny for Millions

Updated Category News Views 464

Data Breach Fallout: Amplifon Under Fire When a big player like Amplifon gets hit with a data breach, it's like a wake-up call across the board. This one’s no small spill—over 1.3 million folks left wondering whether their personal information is fluttering around cyberspace for all who dare to peek. If you’ve missed the memo, Edelson Lechtzin LLP, the savvy cats in...

Continue Reading
ASTS Faces Class Action; Investors Beware of Pitfalls

Updated Category News Views 322

Securities Fraud Allegations Hit AST SpaceMobile Days like this remind me why we keep our eyes peeled in the stock game—AST SpaceMobile (NASDAQ: ASTS) is tangled in a web of legal drama, and it's something you can't brush off with a shrug. Class action lawsuits for securities fraud? That's like finding out the foundation's shaky beneath a skyscraper. If you've got skin...

Continue Reading
JNJ's Dual-Antigen Therapy Shows Promise in Prostate Cancer

Updated Category News Views 360

Exploring a New Front in Cancer Treatment Johnson & Johnson (NYSE: JNJ) just dropped a bombshell at the Society for Immunotherapy of Cancer (SITC) 2026 Annual Meeting, unveiling data that could reshape prostate cancer care. Their pioneering combo of pasritamig and JNJ-9401, a dual-antigen-targeted therapy, has the scientific community buzzing. Yeah, it's just Phase 1 baby...

Continue Reading
Allergan Aesthetics Study Shows Rising Patient Satisfaction

Updated Category News Views 405

Enhanced Patient Satisfaction with Aesthetic Treatments Dive into the latest studies from Allergan Aesthetics—AbbVie's heavyweight in the beauty battleground. If you've got an ounce of optimism left in this market, their recent findings might just lift your spirits. Phase 4 studies, namely HARMONY IN DIVERSITY and HALO, are showing highly positive results among patients...

Continue Reading
Fibocom Unveils U6G Solutions Advancing Global 5G Tech

Updated Category News Views 80

Breaking Barriers with U6G-Capable Technology Sneaking into the industry's spotlight at MWC Doha 2026, Fibocom flaunts a robust lineup of next-gen 5G solutions. It's as if they're shuffling every card they’ve got to win over the broadband world. With breakthroughs like the FG390, FG370, and FG670 modules, alongside PCBA-level innovations, Fibocom is not just throwing...

Continue Reading
LG's ASIL D Certification: A Game Changer in Autos

Updated Category News Views 182

Why LG's ASIL D Certification Matters There ain't much in the tangled mess of automotive innovations these days that'll make a seasoned investor raise an eyebrow, but here comes LG Electronics grabbing the ASIL D certification like it's a badge of market honor. The ISO 26262 ASIL D is no walk in the park, folks—it's the top rung on the safety ladder, something that's...

Continue Reading
Innovent's SINTBILO® Hits Primary Endpoint in Study

Updated Category News Views 146

Innovent's Latest Breakthrough with SINTBILO® One moment you're sipping coffee, the next you're staring at a clinical milestone. Innovent Biologics has shouted from the rooftops that their drug, SINTBILO® (tafolecimab injection), has wrapped up its Phase 3 CREDIT-5 study, snagging the primary endpoint with both hands. This isn't just any drug; it's marked as the first...

Continue Reading

Top 5 Most Recently Viewed Articles

Prodigy Processing Solutions Leads the Charge in Cannabis Extraction

Updated Category News Views 240

Prodigy Processing Solutions Steps into New York's Cannabis Scene Prodigy Processing Solutions is making strides in the cannabis industry by teaming up with ProXtracts Processing Inc., a leading cannabis oil producer, to initiate a pioneering hydrocarbon extraction lab. This collaboration highlights Prodigy's commitment to providing top-notch extraction technologies while...

Continue Reading
Key Details for Moderna Investors Regarding Class Action

Updated Category News Views 69

Important Information for Moderna, Inc. Investors The Gross Law Firm has an important update for shareholders of Moderna, Inc. (NASDAQ: MRNA). If you've purchased shares during the specific class period, you're encouraged to reach out to the firm about possibly serving as lead plaintiffs in an upcoming class action lawsuit. Class Period and Lead Plaintiff Information If...

Continue Reading
Vistagen Therapeutics Investors: Important Legal Update Ahead

Updated Category News Views 117

Vistagen Therapeutics' Legal Challenges: A Summary for Investors As a prominent player in the therapeutic landscape, Vistagen Therapeutics, Inc. (NASDAQ: VTGN) is currently navigating significant legal challenges that investors should be aware of. Legal representation is crucial for those who have invested in the company's stock, particularly following the announcement of...

Continue Reading
Nilfisk Holding A/S Unveils Key 2025 Financial Dates

Updated Category News Views 494

Nilfisk Holding A/S Financial Calendar for 2025 Nilfisk Holding A/S stands out as a prominent global player in the professional cleaning industry, consistently delivering high-quality products and services. As the new year approaches, the company has set forth significant dates for financial disclosures that are vital for investors and stakeholders alike. Upcoming Key...

Continue Reading
Exciting Return of Twang’s Signature Beer and Pickle Salts

Updated Category News Views 332

Exciting Announcement from Twang Twang, a beloved Latino-founded brand, has once again captured the hearts of flavor enthusiasts. Known for its innovative and enticing blends of flavored salts, Twang is thrilled to share the return of two highly anticipated products: Orange Beer Salt and Hot Pickle Flavored Salt. Fans of these tasty seasonings can look forward to their...

Continue Reading